HNB
BIVV

Huntington National Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Huntington National Bank’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-245
Closed -$13K – 1753
2017
Q4 		$13K Sell
245
-4
-2% -$219 ﹤0.01% 1316
2017
Q3 		$14K Buy
+249
New +$14.6K ﹤0.01% 1300

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Huntington National Bank's BIVV Position: Q1 2018 in Review

Huntington National Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 245 shares — an estimated $13K sold.

Huntington National Bank first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $14K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Huntington National Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Huntington National Bank sold 245 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $13K.
  • Huntington National Bank first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Huntington National Bank's Bioverativ Inc. Common Stock position peaked at $14K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Huntington National Bank's 13F filing for Q1 2018, filed 30 Apr 2018.